| Patents for C07D 207 - Heterocyclic compounds containing five-membered rings not condensed with other rings, with one nitrogen atom as the only ring hetero atom (40,304) |
|---|
| 09/26/2002 | WO2002074050A2 Asymmetric synthesis of (s, s, r)-(-)-actinonin and its analogs and uses therefor |
| 09/26/2002 | WO2002044126A3 Bisubstituted carbocyclic cyclophilin binding compounds and theirus |
| 09/26/2002 | WO2002034698A3 Phosgene-free process for preparing carbamates |
| 09/26/2002 | WO2002032872A8 Nitrogenous aromatic ring compounds |
| 09/26/2002 | WO2002028810A3 Retinoids for the treatment of emphysema |
| 09/26/2002 | WO2002024692A8 1-azabicyclo[2.2.2]octan-3-one derivatives and maleimide derivatives and their use for treating cancer tumors |
| 09/26/2002 | WO2002024636A3 N-acylsulfonamide apoptosis promoters |
| 09/26/2002 | WO2002018334B1 Sodium channel modulators |
| 09/26/2002 | WO1997019953A8 New lh-rh antagonists with improved effectiveness |
| 09/26/2002 | US20020137968 Treating with amides, ureas, amidines, carbamates, carboximidamides and other derivatives of given formula, e.g. (+)-N-((2,2-dimethylcyclopentyl)methyl)-4-hexyloxybenzamide |
| 09/26/2002 | US20020137961 Use as skin lightening agents; 4-(1,4-Dioxaspiro(4.5)dec-8-yl)-1,3-benzenediol for example |
| 09/26/2002 | US20020137945 Synthesis of compounds useful in the manufacture of ketorolac |
| 09/26/2002 | US20020137932 Treating autoimmune diseases, Alzheimer's disease, atherosclerosis, osteoporosis, and asthma |
| 09/26/2002 | US20020137931 1,3-disubstituted and 1,3,3-trisubstituted pyrrolidines as histamine-3 receptor ligands and their therapeutic applications |
| 09/26/2002 | US20020137928 Pyrrolothiazine and pyrrolothiazepine compounds having serotonin-2 receptor antagonistic and alpha-1-blocking action |
| 09/26/2002 | US20020137788 Coniosetin and derivatives thereof, process for the preparation and the use thereof |
| 09/26/2002 | US20020137769 Imidazole derivatives having an inhibitory activity for farnesyl transferase and process for preparation thereof |
| 09/26/2002 | US20020137753 Benzoylguanidine salt and hydrates thereof |
| 09/26/2002 | US20020137742 Benzenesulfonamide compounds |
| 09/26/2002 | US20020137687 Novel compounds that inhibit tryptase activity |
| 09/26/2002 | DE10114084A1 New 1,3-diamino-4-aminomethyl-benzene derivatives, useful as coupler substances in oxidative hair dye formulations based on a developer-coupler combination |
| 09/26/2002 | DE10113965A1 New tetrazolylphenyl-substituted 1-pyrroline derivatives useful as pesticides, e.g. insecticides, acaricides, nematocides, ectoparasiticides and antifouling agents |
| 09/26/2002 | DE10113710A1 Oxo-ammonium salts with a sterically-hindered oxo-ammonium group attached to an insoluble support material, used as oxidizing agents, especially for the oxidation of alcohol to ketone or aldehyde |
| 09/26/2002 | CA2445754A1 3-(2,5-diaminophenyl)-acrylamide derivatives and colouring agents containing said compounds |
| 09/26/2002 | CA2441822A1 Asymmetric synthesis of (s, s, r)-(-)-actinonin and its analogs and uses therefor |
| 09/26/2002 | CA2440002A1 Pyrrolidine ester derivatives with oxytocin modulating activity |
| 09/25/2002 | EP1243577A1 Novel phenylalanine derivatives |
| 09/25/2002 | EP1242521A2 Recovery of modifier compounds and polar organic compounds from a poly(arylene sulfide) recycle mixture |
| 09/25/2002 | EP1242471A1 Substituted group 4 metal complexes, catalysts and olefin polymerization process |
| 09/25/2002 | EP1242400A1 Pyrrolidine derivatives as cyclic amp-specific phosphodiesterase inhibitors |
| 09/25/2002 | EP1242374A1 Acryloyl peptidic derivatives, process for their preparation and their use as antitumor agents |
| 09/25/2002 | EP1242373A1 A process for producing crystalline atorvastatin calcium |
| 09/25/2002 | EP1242372A1 Inhibitors of farnesyl protein transferase |
| 09/25/2002 | EP1242371A1 Hydrazone and oxime derivatives of pyrrolidine as amp-specific phosphodiesterase inhibitors |
| 09/25/2002 | EP1242352A2 Chalcone and its analogs as agents for the inhibition of angiogenesis and related disease states |
| 09/25/2002 | EP1241986A1 Use of poly-nitroxyl-functionalized dendrimers as contrast enhancing agents in mri imaging of joints |
| 09/25/2002 | EP0968179B1 N-sulphonyl and n-sulphinyl amino acid amides as microbiocides |
| 09/25/2002 | EP0819676B1 Anhydrous crystals |
| 09/25/2002 | EP0686147B1 Novel 2,2'-bi-1h-pyrrole derivatives with immunosuppressant activity |
| 09/24/2002 | US6455706 Polymerizable compositions containing alkoxyamine compounds derived from nitroso- or nitrone compounds |
| 09/24/2002 | US6455671 Thrombin inhibitors, the preparation and use thereof |
| 09/24/2002 | US6455585 Have a higher analgesic activity, a lower toxicity and a longer effective time period than tramadol. |
| 09/24/2002 | US6455573 Synthesizing salacinol, its stereoisomers, and non-naturally occurring selenium and nitrogen analogues thereof |
| 09/24/2002 | US6455572 Estrogen agonist/antagonist metabolites |
| 09/24/2002 | US6455571 Inhibitors of neuraminidases |
| 09/24/2002 | US6455570 Polypyrrolinone based inhibitors of matrix metalloproteases |
| 09/24/2002 | US6455542 Piperidine and pyrrolidine derivatives comprising a nitric oxide donor for treating stress |
| 09/24/2002 | US6455529 Adhesion receptor antagonists |
| 09/24/2002 | US6455519 Use of substituted N, N-disubstituted fused-heterocyclo amino compounds for inhibiting cholesteryl ester transfer protein activity |
| 09/24/2002 | US6455502 Compounds and compositions as protease inhibitors |
| 09/24/2002 | US6455472 Herbicides, acaricides, nematicides and insecticides for crops |
| 09/24/2002 | CA2220458C Form iii crystalline (r-(r*,r*)-2-(4-fluorophenyl)-beta-delta-dihydroxy-5-(1-methyl-ethyl)-3-phenyl-4-((phenylamino)carbonyl)-1h-pyrrole-1-heptanoic acid hemi calcium salt (atorvastatin) |
| 09/24/2002 | CA2220455C Novel process for the production of amorphous [r-(r*,r*))-2-(4-fluorophenyl)-beta,delta-dihydroxy-5-(1-methylethyl)-3-phenyl-4[(phenylamino)carbonyl]-1h-pyrrole-1-heptanoic acid calcium salt (2:1) |
| 09/19/2002 | WO2002072582A1 Methods for the synthesis of densely functionalized pyrrolidine template libraries |
| 09/19/2002 | WO2002072552A1 Method for preparing amlodipine |
| 09/19/2002 | WO2002072547A1 Amination process |
| 09/19/2002 | WO2002072546A1 Stable crystals of pyrrole compound |
| 09/19/2002 | WO2002072506A2 7-pyrollyl tetracycline compounds and methods of use thereof |
| 09/19/2002 | WO2002072087A1 Pcra helicase inhibitors |
| 09/19/2002 | WO2002072073A2 Pharmaceutical formulation comprising atorvastatin calcium |
| 09/19/2002 | WO2002055519A3 Novel process for the synthesis of 5-(4-fluorophenyl)-1-[2-((2r, 4r)-4-hydroxy -6-oxo-tetrahydro-pyran-2-yl)-ethyl]-2-isopropyl-4-phenyl-1h-pyrrole-3-carboxylic acid phenylamide |
| 09/19/2002 | WO2002024194A9 Use of statins (hmg-coa reductase inhibitors) for the preparation of medicament as a novel type of immunomodulator, immunosuppressor and anti-inflammatory agent |
| 09/19/2002 | WO2001074950A3 Mono- and bis-hydrazone pigments |
| 09/19/2002 | WO2001007020A3 Carboxylic acid amides, medicaments containing these compounds and the use and production thereof |
| 09/19/2002 | US20020133027 New solution and solid phase synthesis of pyrrolinones and polypyrrolinones |
| 09/19/2002 | US20020133026 Novel process for the synthesis of 5-(4-fluorophenyl)-1-[2-((2r,4r)-4-hydroxy-6-oxo-tetrahydro-pyran-2-yl)-ethyl]-2-isopropyl-4-phenyl-1h-pyrrole-3-carboxylic acid phenylamide |
| 09/19/2002 | US20020133020 Efficient synthetic routes for the preparation of rhinovirus protease inhibitors and key intermediates |
| 09/19/2002 | US20020133004 Muscular and gastrointestinal disorders |
| 09/19/2002 | US20020132852 Symmetrically disubstituted aromatic compounds and pharmaceutical compositions for inhibiting poly (ADP-ribose) glycohydrolase, and methods for their use |
| 09/19/2002 | US20020132834 Subjecting a pyrrole derivative, methyl aminocrotonate and 2-chlorobenzaldehyde to a Hantzsch reaction, and converting the pyrrole residue of the resulting product to an amine group by the action of hydroxylamine hydrochloride. |
| 09/19/2002 | US20020132833 Caspase inhibitors and uses thereof |
| 09/19/2002 | US20020131951 Biodegradable poly(beta-amino esters) and uses thereof |
| 09/19/2002 | DE10113027A1 3-Diaminophenyl-acrylamide derivatives or their physiologically acceptable, water-soluble salts, used as developers in combination with couplers in oxidative dye formulations, especially for dyeing hair are new |
| 09/19/2002 | DE10058461A1 Substituierte Cyclohexanderivate und ihre Verwendung Substituted cyclohexane derivatives and their use |
| 09/18/2002 | EP1241162A1 2,2'-bi-1H-pyrrole derivatives with immunosuppressant activity |
| 09/18/2002 | EP1240158A1 1-(aminophenyl)-2-pyrrolidones as integrin inhibitors |
| 09/18/2002 | EP1240140A1 Method for the production of n-alkenyl amides |
| 09/18/2002 | EP1240139A1 Method for producing n-alkenyl amides |
| 09/18/2002 | EP0837847B1 2,4,5-trisubstituted phenylketo-enols for use as pesticides and herbicides |
| 09/18/2002 | EP0828486B1 Use of pyrrolidine derivatives for treating alcoholism |
| 09/18/2002 | EP0823889B1 1,3-propane diol derivatives as bioactive compounds |
| 09/18/2002 | EP0804427B1 Lta4 hydrolase inhibitors |
| 09/18/2002 | CN1370171A Process for preparing inhibitors of nucleoside metabolism |
| 09/17/2002 | US6451974 Method of acylating peptides and novel acylating agents |
| 09/17/2002 | US6451843 Arylphenyl-substituted cyclic keto enols |
| 09/17/2002 | US6451842 Cyclic amine derivatives and their use as drugs |
| 09/17/2002 | US6451836 Method of inhibiting liver glycogen phosphorylase with 2-alkylpyrrolidines |
| 09/17/2002 | US6451830 Use of substituted N,N-disubstituted non-fused heterocyclo amino compounds for inhibiting cholesteryl ester transfer protein activity |
| 09/17/2002 | US6451824 Sulfonylaminocarboxylic acids |
| 09/17/2002 | US6451823 Use of substituted N-phenoxy-N-phenyl aminoalcohol compounds for inhibiting cholesteryl ester transfer protein activity |
| 09/17/2002 | US6451819 Pyrrolidine-3-yl-sulfanyl, or sufonyl or sufinyl derivatives used in the treatment of neurodegenerative diseases |
| 09/17/2002 | US6451803 N-acyl and n-aroyl aralkyl amides useful in treating seritonergic disorders |
| 09/17/2002 | US6451791 Amidoaromatic ring sulfonamide hydroxamic acid compounds |
| 09/17/2002 | US6451736 Substituted aromatic thiocarboxylic acid amides and their use as herbicides |
| 09/12/2002 | WO2002070654A2 Peptide deformylase inhibitors |
| 09/12/2002 | WO2002070541A2 Peptide deformylase inhibitors |
| 09/12/2002 | WO2002070540A2 Peptide deformylase inhibitors |
| 09/12/2002 | WO2002070493A1 Bisaryl derivatives having fsh receptor modulatory activity |
| 09/12/2002 | WO2002070476A1 Phenylpyrroles with a herbicidal activity |
| 09/12/2002 | WO2002070473A2 Carboxamide derivatives as therapeutic agents |